Lydia Koi

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma

Ina Kurth, Linda Hein, Katrin Mäbert et al. · Oncotarget · 2015 · 107 citations · Full text

Treatment Resistance, Tumor Biology, Oncology +18

BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

L. Helbig, Lydia Koi, Kerstin Brüchner et al. · Radiation Oncology · 2014 · 67 citations · Full text

Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential

Lydia Koi, Ralf Bergmann, Kerstin Brüchner et al. · Radiotherapy and Oncology · 2014 · 50 citations

Adaptive Radiotherapy, Radiation Therapy, Theragnostic Potential +10

Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition <i>in vivo</i>

Kristin Gurtner, Zofia Kryzmien, Lydia Koi et al. · International Journal of Cancer · 2019 · 47 citations · Full text

Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography–staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial

Tobias Hölscher, Michaël Baumann, Jörg Kotzerke et al. · European Urology Oncology · 2021 · 41 citations · Full text

Surgical Oncology, Treatment Verification, Ovarian Cancer +24